首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

2058224

合約研究組織 (CRO) 服務市場：按類型、治療領域、最終用戶和地區分類

Contract Research Organization Services Market, By Type, By Therapeutic Application, By End User, By Geography

出版日期: 2026年05月05日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，合約研究組織 (CRO) 服務市場規模將達到 828.6 億美元，到 2033 年將達到 1,375.2 億美元。預計從 2026 年到 2033 年，該市場將以 7.5% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	828.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.50%	2033年市場規模預測：	1375.2億美元

受製藥和生物技術研發外包的增加、全球臨床試驗日益複雜和規模不斷擴大以及對具有成本效益的藥物開發流程的需求不斷成長的推動，市場正在經歷強勁成長。

合約研究組織（CRO）提供廣泛的服務，包括臨床研究、早期開發、實驗室服務和法規諮詢。這些組織在加快藥物發現和開發進程方面發揮著至關重要的作用，同時幫助申辦方控制成本並滿足監管要求。

人工智慧 (AI)、真實世界證據 (RWE) 和分散式臨床試驗 (DCT) 等技術進步正在變革合約研究組織 (CRO) 產業。這些創新透過加強受試者招募、簡化資料收集和縮短試驗週期（最多可縮短 20-30%）來提高試驗效率。此外，對腫瘤、罕見疾病和生物製藥等複雜治療領域的日益關注，進一步推動了對專業 CRO 服務的需求。隨著全球藥物研發管線的不斷擴展，CRO 也不斷發展，成為端到端藥物開發的策略夥伴。

市場動態

由於合約研究組織 (CRO) 在現代藥物研發和臨床研究生態系統中扮演著核心角色，其服務市場正經歷顯著成長。成長要素之一是臨床試驗外包的日益普及，目前約有 65% 至 75% 的臨床研究活動是透過與 CRO 合作進行的。這一趨勢的背後是藥物研發成本的飆升，平均每種藥物的研發成本超過 26 億美元，促使製藥公司尋求更具成本效益和效率的解決方案。

慢性疾病（尤其是癌症）負擔的加重進一步推動了市場需求。腫瘤學仍是主要的治療領域，約佔市場佔有率的30%，這主要得益於免疫療法、標靶治療和個人化醫療等一系列強力的研發管線。全球臨床試驗數量的成長（已註冊的研究超過47萬項）也顯示CRO服務的範圍正在擴大。

監管方面的進步，尤其是在已開發市場，也促進了市場成長。簡化核准流程、提高對真實世界數據（REW）的接受度以及縮短臨床實驗藥物審查週期，都在刺激臨床試驗活動，從而提升了對合約研究組織（CRO）服務的需求。

全球醫藥和生技產業的擴張進一步推動了市場成長。新興地區，尤其是亞太地區，由於營運成本較低、醫療基礎設施完善以及擁有大規模的患者群體，正成為主要的業務外包目的地。這些因素有助於快速招募患者並擴充性的臨床試驗營運。

總體而言，CRO 服務市場作為全球醫療保健生態系統的重要組成部分，不斷發展，實現了高效、擴充性和創新主導的藥物開發流程。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析了 CRO（合約研究組織）服務市場的主要參與者：公司亮點、服務組合、重大發展、財務表現和策略。
透過利用本報告中的見解，行銷負責人和經營團隊將能夠就未來的服務創新、市場擴張和策略夥伴關係關係做出明智的決策。
CRO（合約研究組織）服務市場報告的目標受群眾外包括投資者、服務供應商、製藥公司、監管機構和金融分析師等各類相關人員。
相關人員可以利用用於評估 CRO 服務市場的系統分析框架和策略矩陣來獲得極大的益處。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- IQVIA
- LabCorp
- PAREXEL
- ICON plc
- PPD
- PRA Health Sciences
- Syneos Health
- Charles River Laboratories
- WuXi PharmaTech
- Medpace Holdings
- SGS
- Envigo
- MPI Research

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1592

Contract Research Organization Services Market is estimated to be valued at USD 82.86 Bn in 2026 and is expected to reach USD 137.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 82.86 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.50%	2033 Value Projection:	USD 137.52 Bn

The market is experiencing strong expansion driven by the increasing outsourcing of pharmaceutical and biotechnology research and development (R&D), rising complexity and volume of global clinical trials, and the growing need for cost-efficient drug development processes.

CROs provide a broad spectrum of services including clinical research, early-phase development, laboratory services, and regulatory consulting. These organizations play a critical role in accelerating drug discovery and development timelines while helping sponsors manage costs and regulatory requirements.

Technological advancements such as artificial intelligence (AI), real-world evidence (RWE), and decentralized clinical trials (DCTs) are transforming the CRO landscape. These innovations enhance patient recruitment, streamline data collection, and improve trial efficiency by reducing timelines by up to 20-30%. Additionally, the increasing focus on complex therapeutic areas such as oncology, rare diseases, and biologics is further driving demand for specialized CRO capabilities. As pharmaceutical pipelines expand globally, CROs continue to evolve as strategic partners in end-to-end drug development.

Market Dynamics

The Contract Research Organization Services Market is witnessing significant growth due to its central role in modern drug development and clinical research ecosystems. One of the primary growth drivers is the increasing outsourcing of clinical trials, with approximately 65-75% of clinical research activities now conducted through CRO partnerships. This trend is fueled by the rising cost of drug development, which exceeds USD 2.6 billion per drug on average, prompting pharmaceutical companies to seek cost-effective and efficient solutions.

The growing burden of chronic diseases, particularly cancer, is further accelerating market demand. Oncology remains the leading therapeutic segment, accounting for around 30% of the market share, driven by a strong pipeline of immunotherapies, targeted therapies, and personalized medicine approaches. The increasing number of global clinical trials-exceeding 470,000 registered studies, also highlights the expanding scope of CRO services.

Regulatory advancements, particularly in developed markets, are also contributing to market growth. Streamlined approval processes, increased acceptance of real-world evidence, and faster investigational drug review timelines are encouraging more clinical trial activity, thereby boosting demand for CRO services.

The expansion of the global pharmaceutical and biotechnology sectors further supports market growth. Emerging regions, particularly Asia Pacific, are becoming key outsourcing destinations due to lower operational costs, improved healthcare infrastructure, and access to large patient populations. These factors enable faster patient recruitment and scalable clinical trial operations.

Overall, the CRO services market continues to evolve as a vital component of the global healthcare ecosystem, enabling efficient, scalable, and innovation-driven drug development processes.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Contract Research Organization Services Market based on the following parameters - company highlights, service portfolio, key developments, financial performance, and strategies
Key companies covered as a part of this study include IQVIA, LabCorp, PAREXEL, ICON plc, PPD, PRA Health Sciences, Syneos Health, Charles River Laboratories, WuXi PharmaTech, Medpace Holdings, SGS, Envigo, and MPI Research
Insights from this report would allow marketers and management authorities to make informed decisions regarding future service innovations, market expansion, and strategic partnerships
The Contract Research Organization Services Market report caters to various stakeholders including investors, service providers, pharmaceutical companies, regulatory bodies, and financial analysts
Stakeholders would benefit from structured analytical frameworks and strategy matrices used in evaluating the CRO services market

Market Segmentation

By Type (Revenue, USD Bn, 2021-2033)
- Clinical Research Services
- Early Phase Development Services
- Laboratory Services
- Consulting Services
By Therapeutic Application (Revenue, USD Bn, 2021-2033)
- Oncology
- Infectious Diseases
- Central Nervous System (CNS) Disorders
- Immunological Disorders
- Cardiovascular Diseases
- Respiratory Disorders
- Diabetes
- Other Therapeutic Areas
By End User (Revenue, USD Bn, 2021-2033)
- Pharmaceuticals & Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- IQVIA
- LabCorp
- PAREXEL
- ICON plc
- PPD
- PRA Health Sciences
- Syneos Health
- Charles River Laboratories
- WuXi PharmaTech
- Medpace Holdings
- SGS
- Envigo
- MPI Research

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Contract Research Organization Services Market, By Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Clinical Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Early Phase Development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Consulting Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Contract Research Organization Services Market, By Therapeutic Application, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Central Nervous System (CNS) Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Contract Research Organization Services Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceuticals & Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Contract Research Organization Services Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- IQVIA
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- LabCorp
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- PAREXEL
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- ICON plc
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- PPD
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- PRA Health Sciences
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Syneos Health
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Charles River Laboratories
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- WuXi PharmaTech
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Medpace Holdings
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- SGS
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Envigo
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- MPI Research
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views